Company performance
Add to research
Current Price
as of Jun 18, 2025$0.00
P/E Ratio
N/A
Market Cap
$10
Description
Add to research
DMK Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company provides products in various therapeutic areas, including allergy, respiratory, opioid overdose, and erectile dysfunction markets. It offers the SYMJEPI Injection for the emergency treatment of allergic reactions. The company was founded in June 2006 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerADMP
- Price$0.00010.00%
Trading Information
- Market cap$0.00M
- Float90.75%
- Average Daily Volume (1m)1,145
- Average Daily Volume (3m)2,792
- EPS-$9.18
Company
- Revenue$3.62M
- Rev growth (1yr)115.34%
- Net incomeN/A
- Gross marginN/A
- EBITDA margin-496.05%
- EBITDAN/A
- EVN/A
- EV/Revenue5.21
- P/EN/A
- P/S0.00
- P/BN/A
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Factset Street Account